VICR: Proposed sale of 20,000 shares by insider (Form 144)

Rhea-AI Filing Summary

Notice of proposed resale under Form 144: The filing lists a proposed sale of 20,000 shares of Common stock with an associated amount of $6,916,800.00 and an item labeled 33,863,689 on 05/28/2026. The excerpt also lists multiple prior 10b5-1 sales by an individual (dates and per-trade proceeds are shown).

Insights

Corporate Governance Analyst

Filing documents a proposed resale and shows extensive prior 10b5-1 transactions.

The excerpt records a proposed sale of $6,916,800.00 tied to 20,000 shares on 05/28/2026 and lists many prior 10b5-1 sales with individual trade dates and proceeds. This indicates the selling activity is part of pre-arranged dispositions rather than an ad hoc open-market sale.

Cash-flow treatment and ultimate execution timing are not detailed in the excerpt; subsequent filings or confirmations will show actual execution and proceeds recipients.

Key Figures

Proposed shares to be sold: 20,000 shares Associated amount listed: $6,916,800.00 Line item value: 33,863,689 +2 more

5 metrics

Proposed shares to be sold 20,000 shares line item associated with proposed sale

Associated amount listed $6,916,800.00 amount adjacent to the 20,000-share line dated <date>05/28/2026</date>

Line item value 33,863,689 numeric field present on the same row as the proposed sale dated <date>05/28/2026</date>

Example prior 10b5-1 sale 50,000 shares for $9,660,511.00 trade dated <date>04/15/2026</date> listed as a 10b5-1 sale

Example prior 10b5-1 sale 40,000 shares for $7,905,592.00 trade dated <date>04/16/2026</date> listed as a 10b5-1 sale

Key Terms

10b5-1 Sales, Founders Shares, Securities To Be Sold

3 terms

10b5-1 Sales regulatory

"10b5-1 Sales for PATRIZIO VINCIARELLI 04/15/2026 $9,660,511.00"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Founders Shares financial

"Common | 11/10/1981 | Founders Shares | Issuer"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

Securities To Be Sold regulatory

"144: Securities To Be Sold Common | 11/10/1981"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20000	6916800.00	33863689	05/28/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/10/1981	Founders Shares	Issuer			20000	11/10/1981	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brigham and Women's Hospital 25 Frontage Road Andover MA 01810	Common	05/14/2026	3500	1043623.00
Lahey Hospital & Medical Center 25 Frontage Road Andover MA 01810	Common	05/14/2026	3500	1054410.00
PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	04/24/2026	4000	1092343.20
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	04/16/2026	40000	7905592.00
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	04/15/2026	50000	9660511.00
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	04/14/2026	19778	3748047.00
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	04/09/2026	24943	4670064.00
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/25/2026	50000	9184896.98
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/24/2026	23179	4170596.09
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/23/2026	5924	1039490.00
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/20/2026	44076	7928258.16
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/19/2026	50000	8969588.75
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/18/2026	50000	9809142.46
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/17/2026	50000	9532498.30
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/16/2026	50000	9233644.50
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/13/2026	50000	8542808.13
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/12/2026	50000	8372990.00
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/11/2026	50000	8870435.00
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/10/2026	50000	8862570.00
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/09/2026	50000	8212935.00
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/06/2026	50000	8314785.00
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/05/2026	50000	9341275.00
10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA 01810	Common	03/04/2026	50000	10077245.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the VICR Form 144 report show?

The filing reports a proposed sale of 20,000 shares with an associated amount of $6,916,800.00 and a line item 33,863,689 dated 05/28/2026. It also lists many prior 10b5-1 sales by an individual.

Who conducted the prior 10b5-1 sales noted in the filing?

The excerpt lists multiple prior 10b5-1 sales attributed to Patrizio Venciarelli (name shown) with trade dates and proceeds, including large trades on 03/24/2026 and 04/15/2026 in the filing excerpt.

Does the Form 144 confirm proceeds go to the issuer or selling holder?

The excerpt does not state proceeds recipient explicitly; it lists amounts per trade and labels previous transactions as 10b5-1 Sales. The filing content does not specify whether proceeds are paid to the issuer or selling holders.

Are the previous trades in the filing open-market or pre-arranged?

The filing text labels many prior transactions as 10b5-1 Sales, indicating those trades were executed under pre-arranged plans rather than described as discretionary open-market trades in this excerpt.